These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36018773)

  • 1. A national platform for Covid-19 vaccine studies recruitment in France: Covireivac volunteer's characteristics.
    Bonneton M; Sambourg J; Luong Nguyen LB; Trillou C; Dohou J; Saint Lary O; Schuers M; Lachâtre M; Launay O
    Hum Vaccin Immunother; 2022 Nov; 18(6):2109364. PubMed ID: 36018773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors, motivations and barriers associated with eagerness to volunteer in COVID-19 vaccine clinical trials in France: A mixed-method study.
    Helary A; Botelho-Nevers E; Bonneton M; Khennouf L; Sambourg J; Launay O; Gagneux-Brunon A
    Vaccine; 2024 Jun; ():. PubMed ID: 38910094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit.
    Argyropoulos CD; Leckler J; Salmanton-García J; Constantinou M; Alexandrou A; Themistocleous S; Noula E; Shiamakkides G; Nearchou A; Stewart FA; Albus K; Koniordou M; Kopsidas I; Spivak O; Hellemans M; Hendrickx G; Davis RJ; Azzini AM; Simon PV; Carcas-Sansuan AJ; Askling HH; Vene S; Prellezo JB; Álvarez-Barco E; Macken AJ; Di Marzo R; Luís C; Olesen OF; Frias Iniesta JA; Barta I; Tóth K; Akova M; Bonten MMJ; Cohen-Kandli M; Cox RJ; Součková L; Husa P; Jancoriene L; Launay O; Lundgren J; Mallon P; Armeftis C; Marques L; Naucler P; Ochando J; Tacconelli E; van Damme P; Zaoutis T; Hofstraat S; Bruijning-Verhagen P; Zeitlinger M; Cornely OA; Pana ZD
    JMIR Public Health Surveill; 2023 Apr; 9():e44491. PubMed ID: 36878478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations.
    Manoharan L; Olliaro P; Horby PW; Watson CH
    Trials; 2021 May; 22(1):370. PubMed ID: 34051840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment.
    Salmanton-García J; Stewart FA; Heringer S; Koniordou M; Álvarez-Barco E; Argyropoulos CD; Themistocleous SC; Valle-Simón P; Spivak O; Součková L; Merakou C; Amélia Mendonça M; Joanna Davis R; Maria Azzini A; Askling HH; Vene S; Van Damme P; Steinbach A; Shiamakkides G; Seidel D; Olesen OF; Noula E; Macken A; Luís C; Leckler J; Launay O; Isitt C; Hellemans M; Frías-Iniesta J; Di Marzo R; Carcas AJ; Boustras G; Borobia AM; Barta I; Albus K; Akova M; Ochando J; Cohen-Kandli M; Jane Cox R; Husa P; Jancoriene L; Mallon P; Marques L; Mellinghoff SC; Nauclér P; Tacconelli E; Tóth K; Zaoutis TE; Zeitlinger M; Cornely OA; Pana ZD;
    Vaccine; 2022 Jul; 40(31):4090-4097. PubMed ID: 35659449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®.
    Speich B; Chammartin F; Smith D; Stoeckle MP; Amico P; Eichenberger AL; Hasse B; Schuurmans MM; Müller T; Tamm M; Dickenmann M; Abela IA; Trkola A; Hirsch HH; Manuel O; Cavassini M; Hemkens LG; Briel M; Mueller NJ; Rauch A; Günthard HF; Koller MT; Bucher HC; Kusejko K;
    Trials; 2021 Oct; 22(1):724. PubMed ID: 34674742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond.
    Sethi S; Kumar A; Mandal A; Shaikh M; Hall CA; Kirk JMW; Moss P; Brookes MJ; Basu S
    Trials; 2021 Apr; 22(1):296. PubMed ID: 33879208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engaging Long-Term Care Workers in Research: Recruitment Approaches and Participant Characteristics From a Randomized Controlled Trial to Improve COVID-19 Vaccine Confidence.
    Johnson LC; Stevens G; Cantrell M; Little NR; Holahan TJ; Saunders CH; Thomeer RP; Sheppard R; Elwyn G; Durand MA
    J Am Med Dir Assoc; 2024 Jun; 25(6):104978. PubMed ID: 38588798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An online community peer support intervention to promote COVID-19 vaccine information among essential workers: a randomized trial.
    Ugarte DA; Lin J; Qian T; Young SD
    Ann Med; 2022 Dec; 54(1):3079-3084. PubMed ID: 36314847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why not? Motivations for entering a volunteer register for clinical trials during the COVID-19 pandemic.
    Russo S; Bani M; Terraneo M; Quaglia V; Nuvolati G; Cavaliere R; Capici S; Cazzaniga ME; Strepparava MG
    Eur J Clin Pharmacol; 2022 Nov; 78(11):1791-1800. PubMed ID: 36102931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials.
    Ten Doesschate T; Moorlag SJCFM; van der Vaart TW; Taks E; Debisarun P; Ten Oever J; Bleeker-Rovers CP; Verhagen PB; Lalmohamed A; Ter Heine R; van Crevel R; van de Wijgert J; Janssen AB; Bonten MJ; van Werkhoven CH; Netea MG;
    Trials; 2020 Jun; 21(1):481. PubMed ID: 32503602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.